During my tenure as Executive Medical Director for a global clinical trial, I had the opportunity to observe Anthony in action as the lead BCVA trainer during the Investigator Meeting. He successfully trained over 100 examiners, demonstrating both deep subject matter expertise and an exceptional ability to engage and educate retina clinical site staff.
The impact of the in-person training he conducted was evident in the quality of the BCVA data collected throughout the study. His hands-on approach added significant value, ensuring consistency, validity, and reliability of the visual acuity data across all participating sites. Anthony’s dedication to maintaining high standards in BCVA training is an asset to the retina clinical research community.
Nnenna Ihekoromadu, MD
Founder & CEO,
Ocular Clinical Research Company, LLC
Kind words from: